Victoria Wang

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Prognostic impact of Mantle Cell Lymphoma frontline induction response assessments in the ECOG-ACRIN E1411 study of bendamustine-rituximab +/- bortezomib and maintenance with rituximab +/- lenalidomide

  Blood · 2025-11-03

• Phase II Study of Vismodegib in Patients With <i>SMO-</i> or <i>PTCH1</i> -Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T

  JCO Precision Oncology · 2025-10-01

• Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

  Cell · 2025-08-26 · 21 citations

• Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H

  JCO Precision Oncology · 2025-02-01

• Phase II Study of Defactinib (VS6063) in Patients With Tumors With <i>NF2</i> Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U

  JCO Precision Oncology · 2024-12-01 · 4 citations

• Concurrent laparoscopic hysterectomy and bariatric surgery for early-stage endometrial cancer and endometrial intraepithelial neoplasia: Lessons learned from an interdisciplinary prospective feasibility trial

  Gynecologic Oncology · 2024-10-09 · 1 citations

• Pericardial events associated with ibrutinib‐based therapies for chronic lymphocytic leukaemia in two landmark trials

  British Journal of Haematology · 2024-09-01 · 1 citations